In fact, according to a recent survey, over one-quarter (26%) of consumers in the United States plan to take a weight loss drug to achieve their 2025 New Year's resolution goals. This trend and ...

Weight loss medications like Ozempic and Wegovy have become increasingly popular over the last few years. For people struggling to lose weight through diet and exercise alone, these medications ...

Opens in a new tab or window Just over half of patients with overweight or obesity discontinued their GLP-1 receptor agonist within 1 year ... every 1% of body weight loss was tied to a 3% ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent increase from 2023, according to a Globe analysis of insurance claims data.

Despite the study being short, and people taking the drugs for only 3.5 years because of how ... surprising finding" was the increase in joint pain, since weight loss should reduce pressure ...

Weight gain medications—like some steroid ... Lifting weights and increasing protein intake can increase lean muscle mass over time. Because muscles are denser than fat, becoming stronger ...

The newest weight-loss drugs ... whom were taking the GLP-1 medications and some who took other diabetes treatments. They tracked health outcomes over about four years for 175 different conditions ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

Starting in 2022, Haley Sipes lost 75 pounds over ... year-old mother of three chronicled her weight loss journey, commenters speculated that she was using Ozempic or another weight loss drug.

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.